1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information about our purchases of equity securities that are registered by us pursuant to Section 12 of the Exchange Act during the quarter ended September 30, 2022.
+Added: The following table provides information about our purchases of equity securities that are registered by us pursuant to Section 12 of the Exchange Act during the quarter ended March 31, 2023.
2023 Total Number of Shares Purchased
3 unchanged sentences
(dollars in millions)
−Removed: July 1 - July 31 3,726 $ 92.89 3,726 $ 3,802
−Removed: August 1 - August 31 1,146 93.49 1,146 3,695
−Removed: September 1 - September 30 1,771 84.06 1,771 3,546
+Added: January 1 - January 31 1,475 $ 98.69 1,475 $ 5,822
+Added: February 1 - February 28 1,827 99.41 1,827 5,641
+Added: March 1 - March 31 2,616 97.37 2,616 5,386
Total 5,918 $ 98.33 5,918
On December 12, 2022, our Board of Directors authorized a share repurchase program for up to $6 billion of our common stock, replacing the previous program announced on December 7, 2021.
−Removed: Under this program, shares may be purchased on the open market, in privately negotiated transactions, under accelerated share repurchase programs, and under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.
+Added: Under the 2022 program, shares may be purchased on the open market, in privately negotiated transactions, under accelerated share repurchase programs, and under plans complying
+Added: with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.
We may also reacquire shares outside of the program from time to time in connection with the surrender of shares to cover taxes on vesting of restricted stock and as required under our employee savings plan.
Our ability to repurchase shares is subject to applicable law.
−Removed: No shares were reacquired in transactions outside the program during the quarter ended September 30, 2022.
+Added: No shares were reacquired in transactions outside the program during the quarter ended March 31, 2023.
Number Exhibit Description
+Added: 2023 Schedule of Terms for restricted stock unit awards relating to the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, as amended and restated.*
+Added: 2023 Schedule of Terms for performance share unit awards relating to the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, as amended and restated.*
+Added: 2023 Schedule of Terms for stock appreciation right awards relating to the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, as amended and restated.*
+Added: 2023 Schedule of Terms for stock option awards relating to the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, as amended and restated.*
unaudited interim financial information.*
13 unchanged sentences
Attached as Exhibit 101 to this report are the following formatted in Inline XBRL (Extensible Business Reporting Language):
−Removed: (i) Condensed Consolidated Statement of Operations for the quarters and nine months ended September 30, 2022 and 2021, (ii) Condensed Consolidated Statement of Comprehensive Income for the quarters and nine months ended September 30, 2022 and 2021, (iii) Condensed Consolidated Balance Sheet as of September 30, 2022 and December 31, 2021, (iv) Condensed Consolidated Statement of Cash Flows for the nine months ended September 30, 2022 and 2021, (v) Condensed Consolidated Statement of Changes in Equity for the quarters and nine months ended September 30, 2022 and 2021 and (vi) Notes to Condensed Consolidated Financial Statements.
+Added: (i) Condensed Consolidated Statement of Operations for the quarters ended March 31, 2023 and 2022, (ii) Condensed Consolidated Statement of Comprehensive Income for the quarters ended March 31, 2023 and 2022, (iii) Condensed Consolidated Balance Sheet as of March 31, 2023 and December 31, 2022, (iv) Condensed Consolidated Statement of Cash Flows for the quarters ended March 31, 2023 and 2022, (v) Condensed Consolidated Statement of Changes in Equity for the quarters ended March 31, 2023 and 2022 and (vi) Notes to Condensed Consolidated Financial Statements.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
RAYTHEON TECHNOLOGIES CORPORATION
−Removed: October 25, 2022 By:
+Added: April 25, 2023 By:
MITCHILL, JR.
2 unchanged sentences
(on behalf of the Registrant and as the Registrant’s Principal Financial Officer)
−Removed: October 25, 2022 By:
+Added: April 25, 2023 By:
Corporate Vice President and Controller
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.